Clinical Trial Update: General Practice Research Database Seroquel XR Safety Study

View source ↗

Summary

A completed safety study evaluating quetiapine extended-release (Seroquel XR) in patients with schizophrenia, major depressive disorder, and bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Major Depressive Disorder | Status: COMPLETED